Flash Finance

Procter & Gamble Hygiene and Health Care LimitedPGHHCorporate

Consumer Defensive Household & Personal Products Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹7,169.00
MCap ₹23,271 Cr · P/E 29.4
Procter & Gamble Hygiene and Health Care Limited — Stock analysis & AI research Procter & Gamble Hygiene and Health Care Limited — Seasonality — best & worst months Procter & Gamble Hygiene and Health Care Limited — Technical indicators & charts Procter & Gamble Hygiene and Health Care Limited — Technical setup — score, trend, support & resistance Procter & Gamble Hygiene and Health Care Limited — Descending Channel pattern forming Procter & Gamble Hygiene and Health Care Limited — Live exchange announcements
📋 High ROE Stocks📋 High ROCE Stocks📋 High Operating Margin Stocks📋 High Interest Coverage Stocks📋 Low Debt Stocks📋 High Promoter Holding Stocks 📈 Multi-Timeframe Bearish Stocks 🏭 FMCG sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹891 Cr
Sales · Jun 2026
-4.9% YoY
₹170 Cr
Operating Profit · Jun 2026
-36.1% YoY
19.1%
OPM % · Jun 2026
-32.7% YoY
₹126 Cr
Net Profit · Jun 2026
-34.3% YoY
₹38.90
EPS · Jun 2026
-34.3% YoY

📝 Procter & Gamble Hygiene and Health Care Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Procter & Gamble Hygiene and Health Care Limited reported revenue of ₹891 crore for the quarter ended June 2026 (Q1 FY27), down 4.9% from ₹937 crore in the same quarter last year, and down 5.3% sequentially over the March 2026 quarter.

Net profit fell 34.3% year-on-year to ₹126 crore, from ₹192 crore. Earnings per share (EPS) came in at ₹38.90.

Operating profit stood at ₹170 crore — an operating margin (OPM) of 19.1%, compared with 28.4% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Procter & Gamble Hygiene and Health Care Limited posted revenue of ₹4,290 crore, a decline of 0.4% over FY25, with a net profit of ₹856 crore (up 19.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹4,244 crore with a net profit of ₹790 crore.

Valuation snapshot

At the current price of ₹7,169.00, PGHH has a market capitalisation of ₹23,271 crore and a trailing P/E of about 29.4.

Within the Household & Personal Products industry, it is the 7th-largest of the 9 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 70.64%, foreign institutional investors (FIIs) 0.62%, domestic institutional investors (DIIs) 15.04%, public shareholders 13.70% of Procter & Gamble Hygiene and Health Care Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹23,271 Cr
Current Price ?
₹7,169.0
P/E ?
29.45below ind
Industry P/E ?
35.30
P/B ?
30.90
P/S ?
5.48
P/FCF ?
26.06
Enterprise Value ?
₹23,272 Cr
EV/EBITDA ?
21.65
PEG ?
2.10
Earnings Yield ?
4.5%
Dividend Yield ?
2.37%
Profitability & Returns
Sales (TTM) ?
₹4,244 Cr
OPM ?
25.3%
Profit after tax (TTM) ?
₹790 Cr
EPS (TTM) ?
₹243.45
ROCE ?
157.0%
ROE ?
104.9%
ROA ?
43.8%
Growth
Sales — latest qtr ?
₹891 Cr
PAT — latest qtr ?
₹126 Cr
YoY qtr sales growth ?
-4.9%
YoY qtr profit growth ?
-34.3%
Sales growth (3y) ?
3%
Sales growth (5y) ?
7%
Profit growth (3y) ?
14%
Profit growth (5y) ?
15%
Financial Health
Debt ?
₹1 Cr
Debt to Equity ?
0.00
Interest Coverage ?
112.5
Current Ratio ?
N/A
Ownership
Promoter holding ?
70.64%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-17.8%
Return 6 months ?
-28.3%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 8838531,1381,1331,0029321,1351,2489929371,1501,262941891 -4.9% -5.3%
Operating Profit 149215285310257118290371210266285402218170 -36.1% -22.0%
Other Income 141016161478101981012129 +22.6% -21.4%
Interest 432322027604330 +285.7% -91.0%
Depreciation 15151414151312101099101010 +5.5% -4.1%
Profit Before Tax 146207284309234112285364213265282402218170 -35.9% -22.2%
Net Profit 16515121122915481212269156192210301153126 -34.3% -17.5%
EPS 50.8446.5964.9170.5247.5624.9765.2882.7448.0959.1764.6592.8747.1738.90 -34.3% -17.5%
OPM % 16.9% 25.2% 25.0% 27.4% 25.6% 12.7% 25.6% 29.7% 21.2% 28.4% 24.8% 31.9% 23.2% 19.1% -32.7% -17.7%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹4,307 Cr ₹4,290 Cr ₹4,244 Cr -0.4%
Operating Profit ₹989 Cr ₹1,171 Cr ₹1,075 Cr +18.4%
OPM % 22.96% 27.30% 25.33% +18.9%
NPM % 16.67% 19.95% 18.62% +19.7%
Other Income ₹44 Cr ₹42 Cr ₹43 Cr -5.3%
Depreciation ₹45 Cr ₹38 Cr ₹39 Cr -15.4%
Interest ₹15 Cr ₹10 Cr ₹10 Cr -32.9%
EBIT ₹944 Cr ₹1,133 Cr ₹1,036 Cr +20.0%
PBT ₹974 Cr ₹1,167 Cr ₹1,072 Cr +19.8%
Tax — ₹73 Cr ₹43 Cr —
Net Profit ₹718 Cr ₹856 Cr ₹790 Cr +19.2%
EPS ₹221.08 ₹263.86 ₹243.59 +19.4%
Material Cost — ₹367 Cr ₹413 Cr —
Employee Cost — ₹48 Cr ₹54 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Jun 2023Jun 2024Mar 2025Mar 2026 % Chg
Equity Capital 32323232 +0.0%
Reserves 914742705721 +2.3%
Borrowings 4321 -50.0%
Other Liabilities 1,1871,0811,0151,049 +3.3%
Total Liabilities 2,1371,8591,7551,804 +2.8%
Fixed Assets 170139131163 +24.4%
CWIP 23284121 -48.8%
Investments 0000 —
Other Assets 1,9451,6921,5831,619 +2.3%
Total Assets 2,1371,8591,7551,804 +2.8%

💧 Cash Flow (latest 4 periods)

Metric Jun 2023Jun 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 826470593924 +55.8%
Cash from Investing Activity -101-3411 +132.4%
Cash from Financing Activity -477-861-666-845 -26.9%
Net Cash Flow 339-390-10791 +185.0%
Free Cash Flow 781427539893 +65.7%
CFO/OP 121%79%96%105% +9.4%

➗ Ratios (latest 4 periods)

Metric Jun 2023Jun 2024Mar 2025Mar 2026 % Chg
Debtor Days 20213321 -36.4%
Inventory Days 48516451 -20.3%
Days Payable 213193235197 -16.2%
Cash Conversion Cycle -145-121-138-126 +8.7%
Working Capital Days -53-32-31-31 +0.0%
ROCE % 101%112%104%157% +51.0%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 70.64%70.64%70.64%70.64%70.64% +0.0%
FIIs 1.38%1.11%1.06%0.97%0.62% -36.1%
DIIs 15.49%16.05%16.03%15.96%15.04% -5.8%
Public 12.48%12.19%12.25%12.43%13.70% +10.2%
No. of Shareholders 47,89149,99750,96953,41664,415 +20.6%

⚖️ Peer comparison

Industry: Household & Personal Products · 9 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 HINDUNILVR Hindustan Unilever ₹1,927.00 452,766 30.3 66,374 14,971 23.1% 22.6% 3.8% 41.1% 5.0% -3.2%
2 MARICO Marico ₹802.10 104,111 59.0 13,611 1,813 17.1% 13.3% 35.1% 21.3% 22.1% 18.3%
3 GODREJCP Godrej Consumer ₹865.00 88,516 46.2 16,050 1,914 20.3% 11.9% 7.8% 0.5% 15.4% 11.5%
4 DABUR Dabur India ₹376.00 66,701 33.8 13,552 1,947 18.6% 14.4% 5.0% 7.3% 10.6% 15.3%
5 COLPAL Colgate-Palmolive (India) ₹1,797.40 48,887 36.3 6,204 1,348 30.6% 21.7% -0.1% -7.7% 11.8% 6.9%
6 CUPID Cupid ₹279.70 37,610 272.6 470 137 37.9% 29.1% 104.5% 165.2% 158.7% 194.1%
7 PGHH Procter & Gamble ₹7,520.00 24,410 30.9 4,244 790 25.3% 18.6% -0.4% 19.2% -4.9% -34.3%
8 GILLETTE Gillette India ₹7,305.00 23,804 35.6 3,176 668 30.3% 21.0% 7.6% 22.7% 10.8% 9.2%
9 EMAMILTD Emami ₹364.30 15,902 21.2 3,915 750 24.9% 19.2% -0.8% -3.4% 14.9% -15.4%
❓ Frequently asked questions
What was Procter & Gamble Hygiene and Health Care Limited's revenue in Q1 FY27?
Procter & Gamble Hygiene and Health Care Limited reported revenue of ₹891 crore for the quarter ended June 2026 (Q1 FY27), down 4.9% from ₹937 crore in the same quarter last year, and down 5.3% sequentially over the March 2026 quarter.
What was Procter & Gamble Hygiene and Health Care Limited's net profit in Q1 FY27?
Net profit fell 34.3% year-on-year to ₹126 crore, from ₹192 crore. Earnings per share (EPS) came in at ₹38.90.
What is PGHH's market capitalisation and P/E ratio?
At the current price of ₹7,169.00, PGHH has a market capitalisation of ₹23,271 crore and a trailing P/E of about 29.4.
Who owns Procter & Gamble Hygiene and Health Care Limited? (shareholding pattern)
As of Sep 2026, promoters held 70.64%, foreign institutional investors (FIIs) 0.62%, domestic institutional investors (DIIs) 15.04%, public shareholders 13.70% of Procter & Gamble Hygiene and Health Care Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI